v3.25.4
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2025
SEGMENT REPORTING  
Schedule of Additional disaggregated significant segment expenses

For the Year Ended December 31,

2025

2024

R&D Employee Expenses

$

7,966

$

6,892

R&D Clinical Trial Expenses

5,461

4,330

R&D Professional Fees

157

156

R&D Manufacturing

2,131

1,535

R&D License Fees

2,438

5

G&A Professional Fees

5,253

3,462

G&A Employee Expenses

2,421

2,091

G&A Insurance

599

606

Other Segment Items *

16

(77)

Segment Loss

$

26,442

$

19,000

* - Other Segment Items included in net loss includes interest income, travel and entertainment expenses, printing and information technology expenses.